Literature DB >> 27346704

Active middle ear implant coupled bilaterally to the round window despite bilateral implanted stapes prostheses.

Annekatrin Coordes1, Linda Jahreiss1,2, Uwe Schönfeld1, Minoo Lenarz1.   

Abstract

After stapes surgery, patients with mixed or moderate hearing loss have limited possibilities for hearing improvement. We are reporting on a patient who underwent stapedotomy bilaterally 20 years ago and had sensorineural and mixed hearing loss. Recurrent otitis externa prevented the use of hearing aids. This patient was treated bilaterally with the Vibrant Soundbridge (Med-El, Innsbruck, Austria) successively. The Schuknecht piston stapes prostheses remained in situ. The Floating Mass Transducer (FMT; Med-El) was coupled to the round window (RW) and provided good acoustic reinforcement bilaterally. In conclusion, for patients with otosclerosis and stapes surgery, the FMT-RW coupling (Bess AG, Berlin, DE) is a safe procedure with good acoustic amplification. Laryngoscope, 2016 127:500-503, 2017.
© 2016 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Schuknecht piston; active middle ear implant; otosclerosis; power stapes; stapes plastic; vibrant soundbridge

Mesh:

Year:  2016        PMID: 27346704     DOI: 10.1002/lary.26087

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Modified-Power-Piston: Short-Incudial-Process-Vibroplasty and Simultaneous Stapedotomy in Otosclerosis.

Authors:  Daniel Dejaco; David Riedl; Timo Gottfried; Thomas Rasse; Natalie Fischer; David Prejban; Viktor Koci; Herbert Riechelmann; Joachim Schmutzhard; Thomas Keintzel
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

2.  Modified Power Piston Versus Simultaneous Stapedotomy With Hearing Aids in Otosclerosis: A Follow-Up Study Exploring Speech Recognition, Quality of Life and Usage of Device.

Authors:  Daniel Dejaco; David Riedl; Anna Elisabeth Cassar; Timo Gottfried; Thomas Rasse; Natalie Fischer; Armina Kreuzer-Simonyan; Josef Seebacher; Herbert Riechelmann; Thomas Keintzel; Joachim Schmutzhard
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.